홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /반응

Benzene, 1-iodo-3-(trifluoromethyl)- → 5-bromo-4-methoxy-N-[3-(trifluoromethyl)phenyl]pyrimidin-2-amine

HRID 586
인쇄

반응식

HRID 586 반응식
COc1nc(N)ncc1Br.FC(F)(F)c1cccc(I)c1>CC(=O)O.CC(=O)O.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.Cc1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd]>COc1nc(Nc2cccc(C(F)(F)F)c2)ncc1Br
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 67868Benzene, 1-iodo-3-(trifluoromethyl)-HCID 450369372-Amino-5-bromo-4-methoxypyrimidine

생성물 1

HCID 1069986575-bromo-4-methoxy-N-[3-(trifluoromethyl)phenyl]pyrimidin-2-amine수율 43.23%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약HCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)
촉매
HCID 4144353Palladium (II) acetate촉매
HCID 1140Toluene용매

반응 조건

온도
90 °C

실험 절차

repeat of _EN06995-58\Reaction_ but using Xantphos **_Aim:-_ prepare target for further use.** 1-iodo-3-(trifluoromethyl)benzene (0.171 ml, 1.19 mmol), 5-bromo-4-methoxypyrimidin-2-amine (0.202 g, 0.99 mmol), PALLADIUM(II) ACETATE (0.011 g, 0.05 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) - Xantphos (0.029 g, 0.05 mmol) and cesium carbonate (0.387 g, 1.19 mmol) were mixed in toluene (5ml), purged with nitrogen and stirred in a sealed tube at 90 °C overnight. LCMS: pH = 3, 2 minute run time, shows sign of product at Rt = 1.41 min The reaction mixture was diluted with EtOAc (20 ml), filtered through a celite pad and concentrated to give 477 mg yellow solid. TLC (1:1 - EtOAc : n-heptane) see diagram UV only This was disolved in DCM, absorbed onto a samplet and purified on a 10 g Biotage SNAP column (approx column volume = 7 ml), eluting with a step-wise gradient from 0 : 10 to 4 : 6 EtOAc : n-heptane using a Thomson pump collecting 12 ml fractions. F1 - y = 149 mg - GCMS (Steep_10 min), Rt = 7.88 min (100%) m/z: 346/8. LCMS of F2 did not show anything of interest! **_Conclusion:_ \- ** Seems like xanphos works but could be better - used in EN06995-68

출처 및 근거

ORD 기록
ord-1f9578b402a0413a8d3c28c86e02d21e
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트